POSSIBILITIES TO IMPROVE THE THERAPY OF THE PATIENTS WITH URETERAL CONCRETIONS

  • Maksym Sabadash State Institution Institute of Urology of the National Academy of Medical Sciences in Ukraine, Ukraine
  • Alexandr Shulyak State Institution Institute of Urology of the National Academy of Medical Sciences in Ukraine, Ukraine
  • Pavel Chabanov State Institution Institute of Urology of the National Academy of Medical Sciences in Ukraine, Ukraine
Keywords: urolithiasis disease, extracorporeal shock-wave lithotripsy, phytotherapy

Abstract

The aim of the given study was to improve the results of treatment of patients with concretions of the upper third of the ureter.

Materials and methods. The clinical trial was carried out as a non-interventional open, controlled, in two groups of patients with baseline control. The inclusion criteria concerned the patients with concretions of the upper third of the ureter 0.7-0.9 mm in size, which had one session of an extracorporeal shock-wave lithotripsy (ESWL), and after the procedure the size of the concretions fragments was up to3 mm. The study involved 60 patients, all patients in the main group (n = 30) were treated using phytotherapy, within 1 month starting with basic therapy under hospital conditions and continuing with preventative treatment in an outpatient setting. The control group (n = 30) received baseline therapy (up to 10 days) at the stationary stage.         

Results and discussionIn patients of the main group, fragments of concretions came out significantly faster, namely: in the main group, the fragments came out in 21 patients (70.0 %), while in the control group in 15 patients (50.0 %) (p1- p2, p <0.05) to the 7th day, and in the main group, the fragments came out in one patient more than 14 days, and in the control group – in 5 patients, p <0.05. The "stone path" in the bottom third of the ureter was in 1 patient (3.3 %) of the main group and in 3 patients (10.0 %) in the control group (p1-p2, p <0.05). The "stone path" departure time in patients of the main group was 2 days, and in patients of the control group it was 4.1 days from the time of its formation (p1-p2, p <0.05). Bacteriuria was observed in the main group on the 10th day 6.6 % less relative to the control group.

Conclusion. At comparing the obtained results in patients of both groups in 1 month it was noted that high efficacy of the treatment was registered in 6 (20 %) patients of the main group and in 3 patients (10 %) of the control group (p <0.05), moderate efficiency was registered in 23 (76.7 %) patients of the main group and in 22 (73.3 %) patients of the control group respectively, low efficacy was registered in 1 (3.33 %) patient in the main group and 5 (16.7 %) patients of the control group (p <0,05), which points to the effectiveness of Urolesan capsules use in complex therapy of patients with concretions of the one third of ureter.

Downloads

Download data is not yet available.

Author Biographies

Maksym Sabadash, State Institution Institute of Urology of the National Academy of Medical Sciences in Ukraine

Department of reconstructive and geriatric urology

Alexandr Shulyak, State Institution Institute of Urology of the National Academy of Medical Sciences in Ukraine

Department of reconstructive and geriatric urology

Pavel Chabanov, State Institution Institute of Urology of the National Academy of Medical Sciences in Ukraine

Department of neurourology

References

Vozianov, S. O., Shulyak, O. V., Banyrа, O. B. (2012). Urology. Lviv: Quart Publishing House, 521.

Lopatkin, N. A., Trapeznikova, M. F., Dutov, V. V., Dzeranov, N. K. (2007). Distance shockwave lithotripsy: past, present, future. Urology, 6, 3–13.

Aboumarzouk, O. M., Somani, B. K., Monga, M. (2012). Flexible ureteroscopy and Holmium: YAG laser lithotripsy for stone disease in patients with bleeding diathesis: a systematic review of the literature. International Braz j Urol, 38 (3), 298–306. doi: 10.1590/s1677-55382012000300002

Seitz, C., Liatsikos, E., Porpiglia, F., Tiselius, H.-G., Zwergel, U. (2009). Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence? European Urology, 56 (3), 455–471. doi: 10.1016/j.eururo.2009.06.012

Cooper, J. T., Stack, G. M., Cooper, T. P. (2000). Intensive medical management of ureteral calculi. Urology, 56 (4), 575–578. doi: 10.1016/s0090-4295(00)00658-0

Porpiglia, F., Destefanis, P., Fiori, C., Scarpa, R., Fontana, D. (2002). Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology, 59 (6), 835–838. doi: 10.1016/s0090-4295(02)01553-4

Cervenakov, I., Fillo, J., Mardiak, J., Kopecny, M., Smirala, J., Lepies, P. (2002). Speedy elimination of ureterolithiasis in lower part of ureters with the a1-blocker tamsulosin. International Urology and Nephrology, 34 (1), 25–29. doi: 10.1023/a:1021368325512

Porpiglia, F., Ghignone, G., Fiori, C., Fontana, D., Scarpa, R. M. (2004). Nifedipine versus tamsulosin for the management of lower ureteral stones. The Journal of Urology, 172 (2), 568–571. doi: 10.1097/01.ju.0000132390.61756.ff

Ivanov, D. D., Vozianov, S. O., Kushnirenko, S. V. et. al. (2014). Urolithiasis, dysmetabolic nephropathy, crystalluria. Kyiv, 36.

Zanetti, G. (2011). Ureteral stones: SWL treatment. Arch Ital Urol Androl, 83 (1), 10–13.

Kushnirenko, S. V. (2014). Crystalluria in the practice of family physician. Family medicine, 6, 36–38.

American Association of Urology 2016 (2017). Guidelines on urolithiasis, EAU.

Sagalevich, A. I., Derkach, I. A., Shaparenko, E. V., Loskutov, A. E. et. al. (2010). Minimal invasive methods of treatment of bilateral nephrolithiasis. Urology, 14, 260–262.

Hsieh, C.-H., Yang, S. S.-D., Lin, C.-D., Chang, S.-J. (2014). Are prophylactic antibiotics necessary in patients with preoperative sterile urine undergoing ureterorenoscopic lithotripsy? BJU International, 113 (2), 275–280. doi: 10.1111/bju.12502

Gaponenko, A. D., Dosta, N. I., Nitkin, D. M., Wooed, V. I., Lelyuk, V. Yu., Nenartovich, V. S. (2016). Possibilities of application of the drug Urolesan in the treatment of diseases of the urinary system. Medical News, 4, 16–21.

Miller, O. F., Kane, C. J. (1999). Time to stone passage for observed ureteral calculi: a guide for patient education. The Journal of Urology, 162 (3), 688–691. doi: 10.1097/00005392-199909010-00014

European Association of Urology 2016 (2017). Guidelines on urolithiasis, EAU.

Pain Intensity Instruments. National Institutes of Health. Warren Grant Magnuson Clinical Center (2003). Available at: http://www.mvltca.net/presentations/mvltca.pdf

Furyk, J. S., Chu, K., Banks, C., Greenslade, J., Keijzers, G., Thom, O. et. al. (2016). Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial. Annals of Emergency Medicine, 67 (1), 86–95. doi: 10.1016/j.annemergmed.2015.06.001

Sun, X., He, L., Ge, W., Lv, J. (2009). Efficacy of Selective α1D-Blocker Naftopidil as Medical Expulsive Therapy for Distal Ureteral Stones. The Journal of Urology, 181 (4), 1716–1720. doi: 10.1016/j.juro.2008.11.118

Hollingsworth, J. M., Rogers, M. A., Kaufman, S. R., Bradford, T. J., Saint, S., Wei, J. T., Hollenbeck, B. K. (2006). Medical therapy to facilitate urinary stone passage: a meta-analysis. The Lancet, 368 (9542), 1171–1179. doi: 10.1016/s0140-6736(06)69474-9

Sayed, M. A.-B., El-Taher, A. M., Aboul-Ella, H. A., Shaker, S. E. (2001). Steinstrasse after extracorporeal shockwave lithotripsy: aetiology, prevention and management. BJU International, 88 (7), 675–678. doi: 10.1046/j.1464-4096.2001.02435.x

Coptcoat, M. J., Webb, D. R., Kellet, M. J. et. al. (1988). The steinstrasse: a legacy of extracorporeal lithotripsy? European Urology, 14, 93–95.

Kiseleva, T. L., Smirnov, Yu. A., Blinkov, I. L., Dronov, M. A., Tsvetayeva, E. V.; Kiselevoy, T. L. (2010). A brief encyclopedia of modern phytotherapy with the basics of homeopathy. Moscow: Izd. Of Professional Association of Natural Therapists, 592.

Kurkin, V. A. (2009). Fundamentals of phytotherapy. Samara: OOO "Ofort"; GOU VPO "SamGMUROszdrava", 963.

Chuchalina, A. G., Belousova, Yu. B., Yasnetsova, V. V. (2011). The Federal Manual on the use of medicines (formular system). Vol. 7. Moscow: Echo, 956.

Kiseleva, T. L., Karpeyeva, A. A. (1997). Medicinal herbal raw materials and drugs containing substances that enhance the secretion the function of the kidneys. Homeopathy and phytotherapy in the treatment of cardiovascular diseases. Vol. 2. Moscow: Mosgorpechat, 672–799.


👁 470
⬇ 307
Published
2017-07-31
How to Cite
Sabadash, M., Shulyak, A., & Chabanov, P. (2017). POSSIBILITIES TO IMPROVE THE THERAPY OF THE PATIENTS WITH URETERAL CONCRETIONS. EUREKA: Health Sciences, (4), 3-11. https://doi.org/10.21303/2504-5679.2017.00387
Section
Medicine and Dentistry